BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36877872)

  • 21. Erythema dyschromicum perstans in prepubertal children.
    Silverberg NB; Herz J; Wagner A; Paller AS
    Pediatr Dermatol; 2003; 20(5):398-403. PubMed ID: 14521555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of Cinderella: erythema dyschromicum perstans (ashy dermatosis or dermatosis cinecienta).
    Muñoz C; Chang AL
    Skinmed; 2011; 9(1):63-4. PubMed ID: 21409966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed drug eruption presenting as erythema dyschromicum perstans: a flare without taking any medications.
    Mizukawa Y; Shiohara T
    Dermatology; 1998; 197(4):383-5. PubMed ID: 9873180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythema dyschromicum perstans in an infant with positive Darier sign: A case report successfully treated with tacrolimus.
    Ercan N
    Dermatol Ther; 2020 Nov; 33(6):e14175. PubMed ID: 32779368
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
    Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
    J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Erythema dyschromicum perstans versus lichen planus].
    Leonforte JL; Peláez de di Bari O
    Med Cutan Ibero Lat Am; 1987; 15(1):89-92. PubMed ID: 3298889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with prednisone and isotretinoin in early erythema dyschromicum perstans: A retrospective series.
    Diaz A; Gillihan R; Motaparthi K; Rees A
    JAAD Case Rep; 2020 Mar; 6(3):207-213. PubMed ID: 32149180
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythema dyschromicum perstans showing resolution in an adult.
    Antonov NK; Braverman I; Subtil A; Halasz CL
    JAAD Case Rep; 2015 Jul; 1(4):185-7. PubMed ID: 27051725
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythema dyschromicum perstans: response to dapsone therapy.
    Kontochristopoulos G; Stavropoulos P; Panteleos D; Aroni K
    Int J Dermatol; 1998 Oct; 37(10):796-8. PubMed ID: 9802694
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis).
    Vásquez-Ochoa LA; Isaza-Guzmán DM; Orozco-Mora B; Restrepo-Molina R; Trujillo-Perez J; Tapia FJ
    Int J Dermatol; 2006 Aug; 45(8):937-41. PubMed ID: 16911378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton pump inhibitor-induced erythema dyschromicum perstans-like pigmentation.
    Gutierrez D; Krueger LD; Tan A; Park JH; Lipkin G; Meehan SA
    JAAD Case Rep; 2019 Aug; 5(8):701-703. PubMed ID: 31440561
    [No Abstract]   [Full Text] [Related]  

  • 32. Erythema dyschromicum perstans.
    Tschen JA; Tschen EA; McGavran MH
    J Am Acad Dermatol; 1980 Apr; 2(4):295-302. PubMed ID: 6767758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case for diagnosis.
    Cherobin AC; Oliveira FO; Baeta IG; Vale EC
    An Bras Dermatol; 2012; 87(1):151-2. PubMed ID: 22481670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Erythema cinitiensis perstans].
    Sittart JA; Tayah M
    Med Cutan Ibero Lat Am; 1980; 8(1-3):11-4. PubMed ID: 7022047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo.
    Gross A; Tapia FJ; Mosca W; Perez RM; Briceño L; Henriquez JJ; Convit J
    Histol Histopathol; 1987 Jul; 2(3):277-83. PubMed ID: 2980730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Erythema dyschromicum perstans-ashy dermatosis (EDP-AD). Clinical aspects and problems of classification].
    Rotoli M; Stefanato CM; Rezza E
    G Ital Dermatol Venereol; 1987 Mar; 122(3):119-20. PubMed ID: 3596645
    [No Abstract]   [Full Text] [Related]  

  • 37. Periorbital hyperpigmentation and erythema dyschromicum perstans.
    Ing EB; Buncic JR; Weiser BA; de Nanassy J; Boxall L
    Can J Ophthalmol; 1992 Dec; 27(7):353-5. PubMed ID: 1490247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Erythema dyschromicum perstans revisited.
    Goihman-Yahr M
    Dermatol Online J; 2011 Jan; 17(1):14. PubMed ID: 21272505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythema dyschromicum perstans.
    Knox JM; Dodge BG; Freeman RG
    Arch Dermatol; 1968 Mar; 97(3):262-72. PubMed ID: 5641329
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythema dyschromicum perstans in a child following an enteroviral meningitis.
    Melo CR; Sá MC; Carvalho S
    An Bras Dermatol; 2017; 92(1):137-138. PubMed ID: 28225976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.